Liao et al.86 previously demonstrated upregulation of miR-24 in patients with IBS and SERT as a potential gene target; treatment with miR-24 inhibitor increased colonic pain and nociceptive thresholds in mice. The gene discussed is SLC6A4; the disease is irritable bowel syndrome.